Skip to content

Discontinued — last reported Q1 '26

Net debt at other companies

Sonos, Inc. logo
Sonos, Inc.SONO
-0.4×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-0×-2.5×
Global Net Lease logo
Global Net LeaseGNL
-0.2×-0.1×
Healthcare Services Group logo
Healthcare Services GroupHCSG
-1.3×-22.6×
Global Partners logo
Global PartnersGLP
1.7×+0.2×
Ivanhoe Electric logo
Ivanhoe ElectricIE
-19.6×

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Calculated from AnaptysBio, Inc.’s reported figures.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s net debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s net debt?
AnaptysBio, Inc. (ANAB) reported net debt of -$248.46M in Q1 2026.
How has AnaptysBio, Inc.'s net debt changed year-over-year?
AnaptysBio, Inc.'s net debt decreased by 199.1% year-over-year, from -$83.06M to -$248.46M.
What is the long-term trend for AnaptysBio, Inc.'s net debt?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s net debt has grown at a -1.0% compound annual growth rate (CAGR), from -$250.11M to -$238.18M.
What does net debt mean?
Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.